MedPath

comparison of two doses of cisplatin with radiation in locally advanced head & neck cancers

Not Applicable
Conditions
Health Condition 1: null- locally advanced head & neck carcinomas
Registration Number
CTRI/2013/04/003562
Lead Sponsor
dept of Radiotherapy Oncology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

patients with biopsy proven squamous cell carcinomas of head & neck with stages 3 & 4

patients with ECOG perfomance status 0 to 2

absolute granulocyte count more than 3ooo/mm3

platelet count more than 100000/mm3

normal renal & liver function tests

Exclusion Criteria

patients with metastatic disease on diagnostic imaging

patients with previous history of radiotherapy & treatment for head & neck carcinoma & history of chemotherapy

patients with treatment for any other malignancy

associated serius medical illness like xeroderma pigmentosum, renal failure, cardiac failure, hepatic failure

nasopharyngeal carcinomas, thyroid carcinomas, salivary gland carcinomas

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath